Inventor · disambiguated record
Virginia M. Litwin
Also filed as: LITWIN VIRGINIA M
11 granted patents·8 pending applications·309 citations·filing 1996–2011
92Inventor score
Top patents by PatentIndex Score
19 records- 0195US7345153B2Compounds capable of inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2006·Granted Mar 18, 2008·23 cites·7 claims
- 0292US6344545B1Method for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 1997·Granted Feb 5, 2002·91 cites·6 claims
- 0391US7118859B2Methods for inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2001·Granted Oct 10, 2006·30 cites·8 claims
- 0486US6261763B1Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusionPROGENICS PHARM INC·Filed 1996·Granted Jul 17, 2001·38 cites·9 claims
- 0586US6107019AMethod for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 1997·Granted Aug 22, 2000·78 cites·12 claims
- 0677US7935797B2CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusionPROGENICS PHARM INC·Filed 2007·Granted May 3, 2011·1 cites·1 claims
- 0777US6972126B2Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing samePROGENICS PHARM INC·Filed 1999·Granted Dec 6, 2005·33 cites·3 claims
- 0870US2009155774A1Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cellPROGENICS PHARM INC·Filed 2009·Application pending·0 cites
- 0963US7901685B2Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusionPROGENICS PHARM INC·Filed 2005·Granted Mar 8, 2011·0 cites·3 claims
- 1063US2008226651A1Compounds capable of inhibiting hiv-1 infectionPROGENICS PHARM INC·Filed 2008·Application pending·0 cites
- 1161US5770387AAntibodies to mammalian NK antigens and usesSCHERING CORP·Filed 1996·Granted Jun 23, 1998·14 cites·28 claims
- 1260US7862994B2Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusionPROGENICS PHARM INC·Filed 2001·Granted Jan 4, 2011·0 cites·4 claims
- 1359US2008187539A1Method for preventing HIV-1 infection of CD4 cellsPROGENICS PHARM INC·Filed 2007·Application pending·0 cites
- 1454US2006029932A1Method for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 2005·Application pending·0 cites
- 1554US2006194244A1Uses of a chemokine receptor for inhibiting HIV-1 infectionAARON DIAMONDS AIDS RES CT ADA·Filed 2006·Application pending·0 cites
- 1654US2013211043A1Method for preventing hiv-1 infection of cd4+ cellsALLAWAY GRAHAM P·Filed 2011·Application pending·0 cites
- 1748US2002155429A1Method for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 2001·Application pending·0 cites
- 1844US2004086528A1Uses of a chemokine receptor for inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2001·Application pending·0 cites
- 1939US7858298B1Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonistsPROGENICS PHARM INC·Filed 1999·Granted Dec 28, 2010·1 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Virginia M. Litwin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →